Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adapting and Testing Behavioral Intervention to Prevent Fetal Alcohol Spectrum Disorders and Adverse Infant Outcomes (R33)

NCT07828275 is registered in ClinicalTrials.gov with Philadelphia College of Osteopathic Medicine as lead sponsor.

NCT NCT07828275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07828275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adapting and Testing Behavioral Intervention to Prevent Fetal Alcohol Spectrum Disorders and Adverse Infant Outcomes (R33)
Lead sponsor
Philadelphia College of Osteopathic Medicine
Phase
Phase 2
Overall status
Not yet recruiting
Start date
February 1, 2027
Completion date
June 30, 2029
Enrollment
184 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol and tobacco/cannabis use